Adjuvant Treatment of Melanoma

Table 13

Pegylated interferon. Results of the EORTC 18991 study [57].

	RFS		DMFS		OS
	Obs.	PEG-IFN	Obs.	PEG-IFN	Obs.	PEG-IFN
No. of events	368	328	325	304	263	262
Rates at 4 years	39%	46%	45%	48%	56%	57%
Mean years	2.1	2.9	3.0	3.8	NR	NR
HR (95% CI)	0.82 (0.71–0.96)		0.88 (0.75–1.03)		0.98 (0.82–1.16)
Value of “P”	0.01		0.11		0.78